Clinical trial
Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
NCT00467636 · The Royal Bournemouth Hospital, Other · Terminated
Key facts
| NCT number | NCT00467636 |
|---|---|
| Title | Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations |
| Official title | Influence of Insulin Therapy in Patients Admitted to Hospital With Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
| Lead sponsor | The Royal Bournemouth Hospital, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease, Hyperglycemia |
| Intervention type | Drug, Procedure |
| Interventions | Blood glucose monitoring, Insulin Glulisine |
| Enrollment | 51 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Apr 30, 2007 |
| Last update posted | Oct 2, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: